Cardiology Associations

This page includes news coverage of cardiology societies and associations. Follow these links for specific cardiology society news pages: American College of Cardiology (ACC), American Heart Association (AHA), American Society of Echocardiography (ASE), American Society Nuclear Cardiology (ASNC), European Society of Cardiology (ESC), Heart Rhythm Society (HRS), Society for Cardiovascular Angiography Interventions (SCAI), Society of Cardiovascular Computed Tomography (SCCT), Transcatheter Cardiovascular Therapeutics (TCT), and Vascular Interventional Advances (VIVA).

New balloonless IVL catheter offers an alternative to atherectomy in tight lesions, CTOs
J.D. Corl, MD, shared his experience using two new IVL catheters from Shockwave Medical to treat patients with heavily calcified peripheral arteries. He considers both new devices a significant upgrade.
SCCT leaders unpack the 2025 Medicare payment increase for coronary CTA
The Society of Cardiovascular Computed Tomography is cheering as a “huge win” the 2025 CMS payment increase for coronary CTA that more than doubles the current payment and “better aligns with the cost of providing CCTA services." The panel expects the move to bring an increase in CT utilization, more adoption with financial sustainability and greater access in currently underutilized areas.
No-contact blood pressure and diabetes screening with AI shows promise
The new technology, still under development, could help physicians screen patients for diabetes and hypertension with high-speed video recordings.
Self-expanding vs. balloon-expandable TAVR valves: How they compare after 5 years
SOLVE-TAVI focused on the long-term impact of selecting different second-generation transcatheter heart valves and anesthesia strategies for transfemoral TAVR procedures.
New data put a spotlight on troubling TAVR trends
Philippe Genereux, MD, principal investigator of the EARLY TAVR trial, noted that many patients with severe AS still go untreated.

The Cephea transcatheter mitral valve in development has been acquired by Medtronic.

Abbott acquires another TMVR device through purchase of Cephea

Abbott plans to acquire Cephea Valve Technologies, a company developing a transcatheter mitral valve replacement (TMVR) device, the Chicago-area healthcare giant announced Jan. 16.

January 16, 2019

SCCT shares updated guidance on CT use during TAVI, TAVR procedures

The Society of Cardiovascular Computed Tomography (SCCT) has issued an updated guidance for the use of CT in transcatheter aortic valve implantation (TAVI) and transcatheter aortic valve replacement (TAVR) procedures. The full document can be read in the Journal of Cardiovascular Computed Tomography.

January 9, 2019

Industry group releases new guidelines for CT use in TAVR procedures

The Society of Cardiovascular Computed Tomography (SCCT) released updated guidelines for using CT imaging in patients undergoing transcatheter aortic valve replacement (TAVR).

January 9, 2019

After COAPT: Getting MitraClip Right in the Real World

Will operators be able to replicate COAPT’s restraint and its outcomes?

January 7, 2019

Arizona patients successfully receive the world’s first bioconvertible IVC filter commercially offered in US

BTG plc (LSE: BTG), the global healthcare company, today announced the first patients outside of a clinical trial have been successfully implanted with the BTG Sentry device – the world’s first bioconvertible IVC filter.

December 3, 2018

New Data Continue to Reinforce IN.PACT Admiral DCB as a Durable, Frontline Option to Address Treatment Challenges in PAD

Medtronic data presented today reinforce the durability, safety, and effectiveness of the IN.PACT Admiral drug-coated balloon (DCB) in patients with peripheral artery disease (PAD) in the superficial femoral (SFA) and popliteal arteries.

November 6, 2018

The Eluvia drug-eluting stent continues to demonstrate positive outcomes in long lesion IMPERIAL sub-study

Boston Scientific announced clinical outcomes from the IMPERIAL Long Lesion Sub-study demonstrating that the Eluvia Drug-Eluting Vascular Stent System is safe and effective in treating patients with long, complex, calcified lesions within the superficial femoral and proximal popliteal arteries.

November 6, 2018

Patricia Blake named new CEO of Heart Rhythm Society

Patricia V. Blake will take over as CEO of the Heart Rhythm Society (HRS) next March, HRS leadership announced Oct. 26.

October 26, 2018

Cardiology Associations

New balloonless IVL catheter offers an alternative to atherectomy in tight lesions, CTOs

SCCT leaders unpack the 2025 Medicare payment increase for coronary CTA

No-contact blood pressure and diabetes screening with AI shows promise

Self-expanding vs. balloon-expandable TAVR valves: How they compare after 5 years

New data put a spotlight on troubling TAVR trends